Zengqing R. Guo

No. 420 Fuma Road
Fuzhou, 350014, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 76 publications

Age-dependent prognostic value of biological age for metastasis and survival in gastrointestinal cancer.

Age-dependent prognostic value of biological age for metastasis and survival in gastrointestinal cancer.

Journal: Scientific reports
Published: November 11, 2025

Plasma immune proteome-based risk score predicts survival in advanced gastric cancer treated with PD-1 inhibitors and chemotherapy.

Plasma immune proteome-based risk score predicts survival in advanced gastric cancer treated with PD-1 inhibitors and chemotherapy.

Journal: Frontiers in immunology
Published: September 30, 2025

Identification of plasma lipidomic biomarkers for prognostic stratification in advanced gastric cancer treated with PD-1 inhibitor plus chemotherapy.

Identification of plasma lipidomic biomarkers for prognostic stratification in advanced gastric cancer treated with PD-1 inhibitor plus chemotherapy.

Journal: Frontiers in immunology
Published: September 27, 2025

Hepatic stellate cell derived lipid droplets drive protumoral M2 macrophage polarization in hepatocellular carcinoma.

Hepatic stellate cell derived lipid droplets drive protumoral M2 macrophage polarization in hepatocellular carcinoma.

Journal: Discover oncology
Published: September 04, 2025

Impact of metabolic risk factors on colorectal cancer burden in China: a comprehensive analysis of trends from 1990 to 2021.

Impact of metabolic risk factors on colorectal cancer burden in China: a comprehensive analysis of trends from 1990 to 2021.

Journal: Frontiers in nutrition
Published: August 28, 2025

Safety and preliminary efficacy results of IBI389, an anti-Claudin18.2×CD3 bispecific antibody, in patients with solid tumors and gastric or gastro-esophageal tumors: a phase 1 dose escalation and expansion study.

Safety and preliminary efficacy results of IBI389, an anti-Claudin18.2×CD3 bispecific antibody, in patients with solid tumors and gastric or gastro-esophageal tumors: a phase 1 dose escalation and expansion study.

Journal: BMC medicine
Published: July 30, 2025

Burden of colorectal cancer attributable to dietary risks in China from 1990 to 2021: findings from the Global Burden of Disease Study 2021.

Burden of colorectal cancer attributable to dietary risks in China from 1990 to 2021: findings from the Global Burden of Disease Study 2021.

Journal: Frontiers in nutrition
Published: July 28, 2025

Burden and trends of cancer attributable to occupational asbestos exposure in China from 1990 to 2021.

Burden and trends of cancer attributable to occupational asbestos exposure in China from 1990 to 2021.

Journal: Frontiers in public health
Published: July 24, 2025

Explainable deep learning model WAL-net for individualised assessment of potentially reversible malnutrition in patients with cancer: a multicentre cohort study.

Explainable deep learning model WAL-net for individualised assessment of potentially reversible malnutrition in patients with cancer: a multicentre cohort study.

Journal: The British journal of nutrition
Published: July 10, 2025

Burden, trends, and projections of nutritional deficiencies in China from 1990 to 2030.

Burden, trends, and projections of nutritional deficiencies in China from 1990 to 2030.

Journal: Frontiers in nutrition
Published: June 09, 2025

Impact of weight change on the prognosis of cancer patients: A multicenter, prospective study.

Impact of weight change on the prognosis of cancer patients: A multicenter, prospective study.

Journal: Clinical nutrition ESPEN
Published: May 28, 2025

Impact of high fasting plasma glucose on liver cancer burden in China: a comprehensive analysis of trends from 1990 to 2021.

Impact of high fasting plasma glucose on liver cancer burden in China: a comprehensive analysis of trends from 1990 to 2021.

Journal: Frontiers in nutrition
Published: May 14, 2025
Showing 1-12 of 76

Last Updated: 09/26/2026